Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2010
09/23/2010US20100240716 Thiadiazoline derivative
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240693 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240685 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240676 Thiazole derivatives
09/23/2010US20100240673 EML4-ALK Fusion Gene
09/23/2010US20100240672 Melt-processed imatinib dosage form
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240668 Myosin Light Chain Kinase Inhibitor Compounds, Compositions and Related Methods of Use
09/23/2010US20100240664 Solubilized topoisomerase poison agents
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240657 Chemical compounds
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240651 Water-soluble thalidomide derivatives
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240645 Combination of checkponit kinase (chk) and telangiectasia mutated (atm) inhibitors for the treatment of cancer
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100240638 Organic Compounds and their uses
09/23/2010US20100240637 Inhibitors of the Interaction Between MDM2 and P53
09/23/2010US20100240636 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
09/23/2010US20100240634 Fluorene Compound and Pharmaceutical Use Thereof
09/23/2010US20100240633 Cancer treatment methods
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7
09/23/2010US20100240615 Nitric oxide donors
09/23/2010US20100240613 Pyrimidine compound and medical use thereof
09/23/2010US20100240609 Phthalocyanine salt formulations
09/23/2010US20100240606 Associations of xanthogenates and cyclodextrins, and their use
09/23/2010US20100240605 Novel immunotherapy strategy
09/23/2010US20100240604 Protected nucleotide analogs
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240602 Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds
09/23/2010US20100240601 Coordination Complexes, Pharmaceutical Solutions Comprising Coordination Complexes, and Methods of Treating Patients
09/23/2010US20100240595 Improved Antitumoral Treatments
09/23/2010US20100240594 Targeted delivery of chemotherapeutic agents
09/23/2010US20100240590 Peptides and related molecules that bind to tall-1
09/23/2010US20100240585 In vivo cell surface engineering
09/23/2010US20100240100 Human antibodies that have mn binding and cell adhesion-neutralizing activity
09/23/2010US20100239694 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/23/2010US20100239688 Combination of anti-angiogenic substance and anti-tumor platinum complex
09/23/2010US20100239667 Controlled release pharmaceutical compositions for prolonged effect
09/23/2010US20100239659 Self-assembling amphiphilic polymers as anti-cancer agents
09/23/2010US20100239657 Composite for liver-specific delivery and release of therapeutic nucleic acids or drugs
09/23/2010US20100239656 Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
09/23/2010US20100239654 Vesicular phospholipid gels comprising proteinaceous substances
09/23/2010US20100239653 Pharmaceutical preparations and methods for inhibiting tumors
09/23/2010US20100239652 Immunoliposomes for treatment of cancer
09/23/2010US20100239649 Tumor Suppressor Factor
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239633 Immunoglobulin constant region fc receptor binding agents
09/23/2010US20100239631 Thiopyrimidine-based compounds and uses thereof
09/23/2010US20100239615 Compositions and methods for the therapy and diagnosis of lung cancer
09/23/2010US20100239608 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
09/23/2010US20100239598 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
09/23/2010US20100239596 Grp78 and tumor angiogenesis
09/23/2010US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
09/23/2010US20100239581 Kidney disease targets and uses thereof
09/23/2010US20100239577 Anti-glypican-3 antibody having improved kinetics in plasma
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239571 CD30 Binding Agents and Uses Thereof
09/23/2010US20100239568 Diagnostics and treatments for tumors
09/23/2010US20100239566 Enigma-mdm2 interaction and uses thereof
09/23/2010US20100239564 Novel human growth factors
09/23/2010US20100239553 Methods for promoting cellular health and treatment of cancer
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239547 Synthetic hla binding peptide analogues and uses thereof
09/23/2010US20100239540 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
09/23/2010US20100239532 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239526 Substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds
09/23/2010US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
09/23/2010US20100239522 Chemotherapeutic for inducing an msh2-dependent apoptotic pathway
09/23/2010US20100239512 Adsorption and release of nitric oxide in metal organic frameworks
09/23/2010US20100239497 Oxidized avidin with high residency time in the treated tissues
09/23/2010CA2793797A1 Compounds and biological materials and uses thereof
09/23/2010CA2769276A1 Humanised antibodies with anti-tumour activity
09/23/2010CA2755965A1 Psma-targeting compounds and uses thereof
09/23/2010CA2755790A1 Vaccination methods
09/23/2010CA2755759A1 Substituted pyrimidines for the treatment of cancer
09/23/2010CA2755722A1 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
09/23/2010CA2755686A1 Methods and compositions for bi-specific targeting of cd19/cd22
09/23/2010CA2755660A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010CA2755436A1 Peptides for inhibiting igf-1
09/23/2010CA2755342A1 Neil3 peptides and vaccines including the same
09/23/2010CA2755285A1 Inhibitors of pi3 kinase
09/23/2010CA2754605A1 Compounds
09/22/2010EP2230320A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230242A1 Synthesis of new asymmetrically meso-substituted water-soluble porphyrins acting as cytostatic agents
09/22/2010EP2230235A1 Botryosphaerones, novel depsidones and their use as medicaments
09/22/2010EP2230232A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229941A1 Formulations of suberoylanilide hydroxamic acid and methods for producing same
09/22/2010EP2229824A1 Covalent milk protein/isothiocyanate complexes
09/22/2010EP2229411A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
09/22/2010EP2229405A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases
09/22/2010EP2229401A1 Production and use of antitumoral cyclodepsipeptides
09/22/2010EP2229393A2 3-substituted-4-oxo-3,4-dihydro-imidazo-[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides as anticancer agents
1 ... 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 ... 2211